Page last updated: 2024-08-21

pyrazines and Granulocytic Leukemia, Chronic, Stable Phase

pyrazines has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Hu, Y; Jiang, HW; Li, CG; Mei, H; Peng, YZ; Tang, L; Xu, M; Zhang, H	1
Bunworasate, U; Caguioa, PB; Choi, CW; Chung, JS; Do, YR; Jootar, S; Kim, DW; Kim, H; Kim, HJ; Kim, JA; Kim, SH; Kong, JH; Kwak, JY; Lee, WS; Mun, YC; Oh, SJ; Park, J; Reksodiputro, AH; Shin, HJ; Zang, DY	1
Bunworasate, U; Caguioa, PB; Choi, CW; Chung, JS; Comia, NS; Do, YR; Jootar, S; Jung, CW; Kim, DW; Kim, DY; Kim, H; Kim, HJ; Kim, JA; Kim, SH; Kong, JH; Kwak, JY; Lee, SE; Lee, WS; Mun, YC; Oh, SJ; Park, J; Park, JS; Reksodiputro, AH; Shin, HJ; Zang, DY	1
Cho, DJ; Choi, CW; Chung, JS; Do, YR; Jeong, SH; Jootar, S; Kim, DW; Kim, DY; Kim, H; Kim, HJ; Kim, JA; Kim, SH; Kim, YK; Kwak, JY; Lee, GY; Menon, H; Oh, SJ; Park, HL; Park, JS; Park, S; Saikia, T; Shin, HJ; Shin, JS; Sohn, SK; Zang, DY	1

Trials

3 trial(s) available for pyrazines and Granulocytic Leukemia, Chronic, Stable Phase

Article	Year
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE). British journal of haematology, 2020, Volume: 189, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pyrazines; Treatment Outcome; Young Adult	2020
Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Dec-01, Volume: 23, Issue:23 Topics: Adult; Benzamides; Drug Administration Schedule; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Neutropenia; Protein Kinase Inhibitors; Pyrazines; Remission Induction; Thrombocytopenia; Treatment Outcome	2017
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. Haematologica, 2014, Volume: 99, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Mutation; Piperazines; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Remission Induction; Treatment Outcome; Young Adult	2014

Other Studies

1 other study(ies) available for pyrazines and Granulocytic Leukemia, Chronic, Stable Phase

Article	Year
Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysis. BMC cancer, 2019, Aug-28, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Dasatinib; Dose-Response Relationship, Drug; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Network Meta-Analysis; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Survival Analysis; Treatment Outcome	2019

Article

Year

Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysis.

BMC cancer, 2019, Aug-28, Volume: 19, Issue:1

Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Dasatinib; Dose-Response Relationship, Drug; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Network Meta-Analysis; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Survival Analysis; Treatment Outcome

2019